Product Recalls in Indiana

Product recalls affecting Indiana — including food, drugs, consumer products, medical devices, and vehicles distributed to Indiana. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,049 recalls have been distributed to Indiana in the last 12 months.

53,528 total recalls
2,049 in last 12 months

Showing 1220112220 of 13,412 recalls

DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Lisinopril 20 mg/ml Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Medroxyprogesterone 150 mg/ml Injection Recalled by Lowlite Investments,...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Oxytocin 20 units/ml Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Progesterone EO 100 mg/ml Injection Recalled by Lowlite Investments, Inc....

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Atropine Sulfate 50 mg/ml Injection Recalled by Lowlite Investments, Inc....

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Vitamin A/D3/E Olive Oil Injection Recalled by Lowlite Investments, Inc....

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Dexpanthenol 250 mg/ml Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Voriconazole 5% Ophthalmic drop compounded by Olympia Pharmacy Recalled by...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Acetyl-D-Glucosamine w/Chondroitin 200 mg/ml Recalled by Lowlite...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Metabolase Injection Recalled by Lowlite Investments, Inc. D/B/A Olympia...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Ketamine 100 mg/ml Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Diclazuril 10 mg/ml Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Vitamin B-Buildup Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Metabolase Forte Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Phenylbutazone 200 mg/ml Injection Recalled by Lowlite Investments, Inc....

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Neomycin / Polymyxin / Dexamethasone Ophthalmic Drops Recalled by Lowlite...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: MICC (Methionine Recalled by Lowlite Investments, Inc. D/B/A Olympia...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Cre-O-Pan Injection Recalled by Lowlite Investments, Inc. D/B/A Olympia...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Glutathione 200 mg/ml Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Furosemide 50 mg/ml Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund